高原肺水肿中的炎症与巨噬细胞免疫作用
Inflammation and Macrophage Immunity in High Altitude Pulmonary Edema
DOI: 10.12677/ACM.2024.142585, PDF,   
作者: 李佳文*:青海大学附属医院影像中心,青海 西宁;鲍海华*:青海大学研究生院,青海 西宁
关键词: 肺巨噬细胞炎症HIF高原肺水肿Pulmonary Macrophage Inflammation HIF High Altitude Pulmonary Edema
摘要: 高原肺水肿(High Altitude Pulmonary Edema, HAPE)是机体对低氧环境不同程度适应性导致肺液稳态调节不平衡而引起的高原危重症。目前已有的发生机制主要为血流动力学、渗液机制、肺水清除障碍、炎症反应等。缺氧诱导的炎症机制参与了HAPE,肺泡和肺血管壁中最突出的炎症细胞类型是巨噬细胞。本研究拟通过综述类形式从炎症与巨噬细胞免疫作用角度谈HAPE的发病机制及研究进展,以期对HAPE的研究及临床预防和(或)治疗具有一定推动作用。
Abstract: High Altitude Pulmonary Edema (HAPE) is a critical illness caused by imbalance of lung fluid ho-meostasis regulation due to different degrees of adaptation to low oxygen environment. Currently, the main mechanisms of HAPE are hemodynamics, exudate mechanism, impaired lung water clear-ance, and inflammatory response. Hypoxia-induced inflammatory mechanisms are involved in HAPE, and the most prominent inflammatory cell type in the alveolar and pulmonary vascular walls are macrophages. This study intends to discuss the pathogenesis and research progress of HAPE from the perspective of inflammation and macrophage immune action in the form of a review class, in order to have a promotion effect on the research and clinical prevention and/or treatment of HAPE.
文章引用:李佳文, 鲍海华. 高原肺水肿中的炎症与巨噬细胞免疫作用[J]. 临床医学进展, 2024, 14(2): 4227-4233. https://doi.org/10.12677/ACM.2024.142585

参考文献

[1] 付兴, 付义. 高原肺水肿发病机制及中医药防治研究进展[J]. 中国中医基础医学杂志, 2019, 25(4): 563-566.
[2] Pugliese, S.C., Poth, J.M., Fini, M.A., Olschewski, A., El Kasmi, K.C. and Stenmark, K.R. (2015) The Role of Inflammation in Hypoxic Pulmonary Hypertension: From Cellular Mechanisms to Clinical Phenotypes. American Journal of Physiology-Lung Cellular and Molecular Physiology, 308, L229-L252. [Google Scholar] [CrossRef] [PubMed]
[3] Swenson, E.R. (2020) Early Hours in the Development of High-Altitude Pulmonary Edema: Time Course and Mechanisms. Journal of Applied Physiology, 128, 1539-1546. [Google Scholar] [CrossRef] [PubMed]
[4] Kubo, K., Hanaoka, M., Hayano, T., Miyahara, T., Hachiya, T., Hayasaka, M., et al. (1998) Inflammatory Cytokines in BAL Fluid and Pulmonary Hemodynamics in High-Altitude Pulmonary Edema. Respiration Physiology, 111, 301-310. [Google Scholar] [CrossRef
[5] Schoene, R.B., Swenson, E.R., Pizzo, C.J., Hackett, P.H., Roach, R.C., Mills Jr., et al. (1988) The Lung at High Altitude: Bronchoalveolar Lavage in Acute Mountain Sickness and Pulmonary Edema. Journal of Applied Physiology, 64, 2605-2613. [Google Scholar] [CrossRef] [PubMed]
[6] Stenmark, K.R., Davie, N.J., Reeves, J.T. and Frid, M.G. (2005) Hypoxia, Leukocytes, and the Pulmonary Circulation. Journal of Applied Physiology, 98, 715-721. [Google Scholar] [CrossRef] [PubMed]
[7] 高钰琪, 高文祥, 袁志兵, 等. 低氧肺血管炎症反应是高原肺水肿和低氧性肺动脉高压形成的关键环节[J]. 中国病理生理杂志, 2015, 31(10): 1903.
[8] Li, Y., Zhang, Y. and Zhang, Y. (2018) Research Advance in Pathogenesis and Prophylactic Measures of Acute High Altitude Illness. Respiratory Medicine, 145, 145-152. [Google Scholar] [CrossRef] [PubMed]
[9] 刘杰, 曹成珠, 纪巧荣, 等. 不同急性低氧条件下SD大鼠肺肥大细胞的变化趋势[J]. 中国高原医学与生物学杂志, 2020, 41(1): 24-32.
[10] Fu, X., Yang, C., Chen, B., Zeng, K., Chen, S. and Fu, Y. (2021) Qi-Long-Tian Formula Extract Alleviates Symptoms of Acute High-Altitude Diseases via Suppressing the Inflammation Responses in Rat. Respiratory Research, 22, Article No. 52. [Google Scholar] [CrossRef] [PubMed]
[11] Pugliese, S.C., Kumar, S., Janssen, W.J., Graham, B.B., Frid, M.G., Riddle, S.R., et al. (2017) A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension. The Journal of Immunology, 198, 4802-4812. [Google Scholar] [CrossRef] [PubMed]
[12] Frid, M.G., Brunetti, J.A., Burke, D.L., Carpenter, T.C., Davie, N.J., Reeves, J.T., et al. (2006) Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage Lineage. The American Journal of Pathology, 168, 659-669. [Google Scholar] [CrossRef] [PubMed]
[13] Ensan, S., Li, A., Besla, R., Degousee, N., Cosme, J., Roufaiel, M., et al. (2016) Self-Renewing Resident Arterial Macrophages Arise from Embryonic CX3CR1+ Precursors and Cir-culating Monocytes Immediately after Birth. Nature Immunology, 17, 159-168. [Google Scholar] [CrossRef] [PubMed]
[14] 范勇, 史玉玲, 刘杰. 高原肺水肿发病机制及防治研究进展[J]. 河南中医, 2023, 43(9): 1435-1444.
[15] Lewis, C. and Murdoch, C. (2005) Macrophage Responses to Hypoxia: Implications for Tumor Progression and Anti-Cancer Therapies. The American Journal of Pathology, 167, 627-635. [Google Scholar] [CrossRef
[16] Mosser, D.M. and Edwards, J.P. (2008) Exploring the Full Spectrum of Macrophage Activation. Nature Reviews Immunology, 8, 958-969. [Google Scholar] [CrossRef] [PubMed]
[17] Edwards, J.P., Zhang, X., Frauwirth, K.A. and Mosser, D.M. (2006) Bio-chemical and Functional Characterization of Three Activated Macrophage Populations. Journal of Leukocyte Biology, 80, 1298-1307. [Google Scholar] [CrossRef] [PubMed]
[18] Murray, P.J., Allen, J.E., Biswas, S.K., Fisher, E.A., Gilroy, D.W. and Goerdt, S. (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity, 41, 14-20. [Google Scholar] [CrossRef] [PubMed]
[19] Mora, A.L., Torres-Gonzalez, E., Rojas, M., Corredor, C., Ritzenthaler, J., Xu, J., et al. (2006) Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus Induced Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 35, 466-473. [Google Scholar] [CrossRef
[20] Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B.G., O’Connor, T.P. and Crystal, R.G. (2009) Smoking-Dependent Reprogramming of Alveolar Macrophage Polari-zation: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease. The Journal of Immunology, 183, 2867-2883. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, H., Wang, Y., Zhang, Q., Liu, C., Ma, Y., Huang, P., Ge, R. and Ma, L. (2023) Macrophage-Derived Inflammation Promotes Pulmonary Vascular Remodeling in Hypoxia-Induced Pulmonary Arterial Hypertension Mice. Immunol Lett, 263, 113-122. [Google Scholar] [CrossRef] [PubMed]
[22] Vergadi, E., Chang, M.S., Lee, C., Liang, O.D., Liu, X., Fer-nandez-Gonzalez, A., et al. (2011) Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension. Circulation, 123, 1986-1995. [Google Scholar] [CrossRef
[23] Roca, H., Varsos, Z.S., Sud, S., Craig, M.J., Ying, C. and Pienta, K.J. (2009) CCL2 and IL-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-Type Macrophage Polarization. Journal of Biological Chemistry, 284, 34342-34354. [Google Scholar] [CrossRef
[24] Teng, X., Li, D., Champion, H.C. and Johns, R.A. (2003) FIZZ1/RELMα, a Novel Hypoxia-Induced Mitogenic Factor in Lung with Vasoconstrictive and Angiogenic Properties. Circulation Research, 92, 1065-1067. [Google Scholar] [CrossRef
[25] Chao, J., Donham, P., Van Rooijen, N., Wood, J.G. and Gonzalez, N.C. (2011) Monocyte Chemoattractant Protein-1 Released from Alveolar Macrophages Mediates the Systemic Inflammation of Acute Alveolar Hypoxia. American Journal of Respiratory Cell and Molecular Biology, 45, 53-61. [Google Scholar] [CrossRef
[26] Chao, J., Wood, J.G. and Gonzalez, N.C. (2009) Alveolar Hypoxia, Alveolar Macrophages, and Systemic Inflammation. Respiratory Research, 10, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[27] 麻海英, 洒玉萍, 沈慧萍, 等. 血管紧张素转化酶、血管紧张素Ⅱ在高原肺水肿中的相关研究进展[J]. 吉林医学, 2021, 42(3): 741-743.
[28] Gonzalez, N.C., Allen, J., Blanco, V.G., Schmidt, E.J., Van Rooijen, N. and Wood, J.G. (2007) Alveolar Macrophages Are Necessary for the Systemic In-flammation of Acute Alveolar Hypoxia. Journal of Applied Physiology, 103, 1386-1394. [Google Scholar] [CrossRef] [PubMed]
[29] Ye, Y., Xu, Q. and Wuren, T. (2023) Inflammation and Immunity in the Pathogenesis of Hypoxic Pulmonary Hypertension. Frontiers in Immunology, 14, Article 1162556. [Google Scholar] [CrossRef] [PubMed]
[30] Richalet, J.P., Jeny, F., Callard, P. and Bernaudin, J.F. (2023) High-Altitude Pulmonary Edema: the Intercellular Network Hypothesis. American Journal of Physiology-Lung Cellular and Molecular Physiology, 325, L155-L173. [Google Scholar] [CrossRef] [PubMed]
[31] Spiekerkoetter, E., Goncharova, E.A., Guignabert, C., Stenmark, K., Kwapiszewska, G. and Rabinovitch, M. (2019) Hot Topics in the Mechanisms of Pulmonary Arterial Hypertension Disease: Cancer-Like Pathobiology, the Role of the Adventitia, Systemic Involvement, and Right Ventricular Failure. Pulmonary Circulation, 9, 1-15. [Google Scholar] [CrossRef] [PubMed]
[32] Buckley, C.D., Barone, F. and Nayar, S. (2015) Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation. Annual Review of Immunology, 33, 715-745. [Google Scholar] [CrossRef] [PubMed]
[33] Libby, P. (2015) Fanning the Flames: Inflammation in Cardiovascular Diseases. Cardiovascular Research, 107, 307-309. [Google Scholar] [CrossRef] [PubMed]
[34] Libby, P. and Hansson, G.K. (2015) Inflammation and Immunity in Dis-eases of the Arterial Tree: Players and Layers. Circulation Research, 116, 307-311. [Google Scholar] [CrossRef
[35] Maiellaro, K. and Taylor, W.R. (2007) The Role of the Adventitia in Vascular Inflammation. Cardiovascular Research, 75, 640-648. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, J., Wang, Y. and Wang, J. (2018) Adventitial Activa-tion in the Pathogenesis of Injury-Induced Arterial Remodeling: Potential Implications in Transplant Vasculopathy. The American Journal of Pathology, 188, 838-845. [Google Scholar] [CrossRef] [PubMed]
[37] Stenmark, K.R., Yeager, M.E. and El Kasmi, K.C. (2013) The Adventitia: Essential Regulator of Vascular Wall Structure and Function. Annual Review of Physiology, 75, 23-47. [Google Scholar] [CrossRef] [PubMed]
[38] Majesky, M.W., Dong, X.R. and Hoglund, V. (2011) The Adventitia: A Dynamic Interface Containing Resident Progenitor Cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 1530-1539. [Google Scholar] [CrossRef
[39] El Kasmi, K.C., Pugliese, S.C., Riddle, S.R., Poth, J.M., Anderson, A.L. and Frid, M.G. (2014) Adventitial Fibroblasts Induce a Distinct Proinflammatory/Profibrotic Macro-phage Phenotype in Pulmonary Hypertension. The Journal of Immunology, 193, 597-609. [Google Scholar] [CrossRef] [PubMed]
[40] Kuebler, W.M., Bonnet, S. and Tabuchi, A. (2018) Inflammation and Autoimmunity in Pulmonary Hypertension: Is There a Role for Endothelial Adhesion Molecules? (2017 Grover Conference Series). Pulmonary Circulation, 8, 1-13. [Google Scholar] [CrossRef] [PubMed]
[41] Hu, Y., Chi, L., Kuebler, W.M. and Goldenberg, N.M. (2020) Perivascular Inflammation in Pulmonary Arterial Hypertension. Cells, 9, Article 2338. [Google Scholar] [CrossRef] [PubMed]
[42] Sun, W. and Chan, S.Y. (2018) Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension. Frontiers in Medicine (Lausanne), 5, Article 204. [Google Scholar] [CrossRef] [PubMed]
[43] Lammers, S., Scott, D., Hunter, K., Tan, W., Shandas, R. and Stenmark, K.R. (2012) Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function. Comprehensive Physiology, 2, 295-319. [Google Scholar] [CrossRef] [PubMed]
[44] Savai, R., Pullamsetti, S.S., Kolbe, J., Bieniek, E., Voswinckel, R. and Fink, L. (2012) Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hyper-tension. American Journal of Respiratory and Critical Care Medicine, 186, 897-908. [Google Scholar] [CrossRef
[45] Chi, P.L., Cheng, C.C., Hung, C.C., Wang, M.T., Liu, H.Y. and Ke, M.W. (2022) MMP-10 from M1 Macrophages Promotes Pulmonary Vascular Remodeling and Pulmonary Ar-terial Hypertension. International Journal of Biological Sciences, 18, 331-348. [Google Scholar] [CrossRef] [PubMed]
[46] Lepetit, H., Eddahibi, S., Fadel, E., Frisdal, E., Munaut, C. and Noel, A. (2005) Smooth Muscle Cell Matrix Metalloproteinases in Idiopathic Pulmonary Arterial Hypertension. European Res-piratory Journal, 25, 834-842. [Google Scholar] [CrossRef] [PubMed]
[47] Bendeck, M.P., Irvin, C. and Reidy, M.A. (1996) Inhibition of Matrix Metalloproteinase Activity Inhibits Smooth Muscle Cell Migration but Not Neointimal Thickening after Arterial Injury. Circulation Research, 78, 38-43. [Google Scholar] [CrossRef
[48] Barman, S.A., Chen, F., Su, Y., Dimitropoulou, C., Wang, Y. and Catravas, J.D. (2014) NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1704-1715. [Google Scholar] [CrossRef
[49] Wang, Z., Lakes, R.S., Eickhoff, J.C. and Chesler, N.C. (2013) Effects of Collagen Deposition on Passive and Active Mechanical Properties of Large Pulmonary Arteries in Hypoxic Pulmonary Hypertension. Biomechanics and Modeling in Mechanobiology, 12, 1115-1125. [Google Scholar] [CrossRef] [PubMed]
[50] Franz, M., Grun, K., Betge, S., Rohm, I., Ndongson-Dongmo, B. and Bauer, R. (2016) Lung Tissue Remodelling in MCT-Induced Pulmonary Hypertension: A Proposal for a Novel Scoring System and Changes in Extracellular Matrix and Fibrosis Associated Gene Expression. Oncotarget, 7, 81241-81254. [Google Scholar] [CrossRef] [PubMed]
[51] Ntokou, A., Dave, J.M., Kauffman, A.C., Sauler, M., Ryu, C., Hwa, J., et al. (2021) Macrophage-Derived PDGF-b Induces Muscularization in Murine and Human Pulmonary Hypertension. JCI Insight, 6, e139067. [Google Scholar] [CrossRef] [PubMed]
[52] Steiner, M.K., Syrkina, O.L., Kolliputi, N., Mark, E.J., Hales, C.A. and Waxman, A.B. (2009) Interleukin-6 Overexpression Induces Pulmonary Hypertension. Circulation Research, 104, 236-244. [Google Scholar] [CrossRef
[53] D’Ignazio, L., Batie, M. and Rocha, S. (2017) Hypoxia and Inflammation in Cancer, Focus on HIF and NF-kB. Biomedicines, 5, Article 21. [Google Scholar] [CrossRef] [PubMed]
[54] Jin, F., Zheng, X., Yang, Y., Yao, G., Ye, L. and Doeppner, T.R. (2019) Impairment of Hypoxia-Induced Angiogenesis by LDL Involves a HIF-Centered Signaling Network Linking Inflammatory TNFα and Angiogenic VEGF. Aging (Albany NY), 11, 328-349. [Google Scholar] [CrossRef] [PubMed]
[55] Canton, M., Sanchez-Rodrıguez, R., Spera, I., Venegas, F.C., Favia, M. and Viola, A. (2021) Reactive Oxygen Species in Macrophages: Sources and Target. Frontiers in Immunology, 12, Article 734229. [Google Scholar] [CrossRef] [PubMed]
[56] Khawaja, A.A., Chong, D.L.W., Sahota, J., Mikolasch, T.A., Pericleous, C. and Ripoll, V.M. (2020) Identification of a Novel HIF-1α-αMβ2 Integrin-NET Axis in Fibrotic Interstitial Lung Disease. Frontiers in Immunology, 11, Article 2190. [Google Scholar] [CrossRef] [PubMed]
[57] Walmsley, S.R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R.S. and Cramer, T. (2005) Hypoxia-Induced Neutrophil Survival Is Mediated by HIF-1α-Dependent NF-κB Activity. Journal of Experimental Medicine, 201, 105-115. [Google Scholar] [CrossRef] [PubMed]